Question:

What specifically labeled immunosuppressive drugs are approved by the FDA for marketing?

Answer:

The following drugs have been identified and approved for marketing by the FDA:

  • Sandimmune (cyclosporine), Sandoz Pharmaceutical Imuran (azathioprine), Burroughs Wellcome;
  • Atgam (antithymocyte globulin), Upjohn;
  • Orthoclone OKT3 (Muromonab-CD3), Ortho Pharmaceutical;
  • Prograf (tacrolimus), Fujisawa USA, Inc;
  • Celicept (mycophenolate mefetil, Roche Laboratories;
  • Daclizumab (Zenapax);
  • Cyclophosphamide (Cytoxan); Prednisone; and Prednosolone.
Facebook
Twitter
LinkedIn
Email
Print

CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.